Piramal Pharma Limited announced levying the following penalties: INR 9,335,983 under the Cenvat Credit Rules, 2004 and Central Excise Act, 1944 by way of an order dated June 27, 2024 passed by the Joint Commissioner, C.G.S.T & Central Excise Headquarters, Ujjain, disallowing cenvat credit on certain category of services; and INR 58,661,571 under Central Goods and Services Tax, 2017 by way of an order dated May 31, 2024 passed by the Joint Commissioner, C.G.S.T & Central Excise, Commissionerate Indore, alleging mixed supply of goods and that this is subject to higher rate of GST; (collectively `Orders').
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
966.6 INR | +2.26% |
|
+4.80% | +3.81% |
06:13am | Jefferies Forecasts Strong Fiscal Q1 for Indian Pharmaceuticals | MT |
07-08 | Piramal Enterprises Limited Approves Final Dividend for the Financial Year Ended 31St March, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.78% | 2.55B | |
-3.65% | 52.24B | |
-4.68% | 30.56B | |
+52.56% | 27.02B | |
+39.42% | 26.64B | |
+32.81% | 20.37B | |
+12.09% | 14.21B | |
+24.64% | 8.82B | |
+167.45% | 8.04B | |
-26.33% | 7.75B |
- Stock Market
- Equities
- PEL Stock
- News Piramal Enterprises Limited
- Piramal Enterprises Limited Receives Levying Penalties